Beauty Farm Medical and Health Industry Inc. (stock code: 02373) will convene its board of directors in Hong Kong on Friday, 27 March 2026 to review and approve the consolidated financial results for the year ended 31 December 2025 and to consider a final-dividend recommendation.
Following board approval, the audited annual results will be released on the company’s investor-relations website (https://ir.beautyfarm.com.cn) and on the HKEX news website (www.hkexnews.hk).
Management will host an earnings conference call on the same day at 3:00 p.m. Hong Kong time. Investors may register in advance via the meeting link (https://s.comein.cn/h7qn5yks) using passcode 384138.
The board currently comprises one chairman and executive director, one vice-chairman and executive director, three non-executive directors and three independent non-executive directors, as detailed in the announcement dated 13 March 2026.